Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review ; volume:23 ; number:1 ; day:11 ; month:11 ; year:2024 ; pages:1-10 ; date:12.2024
Annals of general psychiatry ; 23, Heft 1 (11.11.2024), 1-10, 12.2024

Creator: Lee, Serene
Li, Maggie
Le, Gia Han
Teopiz, Kayla M.
Vinberg, Maj
Ho, Roger
Au, Hezekiah C. T.
Wong, Sabrina
Valentino, Kyle
Kwan, Angela T. H.
Rosenblat, Joshua D.
McIntyre, Roger S.

Contributor: SpringerLink (Online service)

DOI: 10.1186/s12991-024-00527-9

URN: urn:nbn:de:101:1-2501282111569.699712480370

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:37 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Lee, Serene
Li, Maggie
Le, Gia Han
Teopiz, Kayla M.
Vinberg, Maj
Ho, Roger
Au, Hezekiah C. T.
Wong, Sabrina
Valentino, Kyle
Kwan, Angela T. H.
Rosenblat, Joshua D.
McIntyre, Roger S.
SpringerLink (Online service)

Other Objects (12)

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide 1 (GLP-1)

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review

Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate

Hochschulschrift

Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors

„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide 1 (GLP-1)

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review

Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate

Hochschulschrift

Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors

„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide 1 (GLP-1)

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review

Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate

Hochschulschrift

Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors

„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Glucagon-like peptide-1 receptor agonists (GLP-1RAs) as treatment for nicotine cessation in psychiatric populations: a systematic review

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide 1 (GLP-1)

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review

Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate

Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors

„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide 1 (GLP-1)

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review

Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate

Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors

„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)

Glucagon-like peptide-1 (GLP-1) receptor agonists: Differentiating the new medications

Glucagon-like peptide 1 (GLP-1)

Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs) in the Brain–Adipocyte Axis

Glucagon-like peptide-1 (GLP-1) receptor agonists and their cardiovascular benefits : the role of the GLP-1 receptor

Glucagon-like peptide-1 (GLP-1) receptor agonists for headache and pain disorders: a systematic review

Contemporary Classification of Glucagon-Like Peptide 1 Receptor Agonists (GLP1RAs)

Glucagon-like peptide (GLP)-1 regulation of lipid and lipoprotein metabolism

Differential effects of glucagon-like peptide-1 receptor agonists on heart rate

Untersuchungen zur Ligandspezifität und Langzeitdesensitivierung des Glucagon-like petide-1 (GLP-1)-Rezeptors

„Glucagon-like peptide‑1“(GLP‑1)-Rezeptor-Agonisten – die neuen Wunderwaffen in der Adipositastherapie?

Glucagon-like peptide-1 and glucagon-like peptide-2 regulation during human liver regeneration

Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM)

Related objects

Reset password